{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:09:31Z","timestamp":1774616971636,"version":"3.50.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In status asthmaticus (SA), severe bronchial inflammation is associated with acute respiratory failure. Neutrophils are the prominent cells found in bronchi from SA patients, but eosinophils are also recruited within the first 48 h after the beginning of mechanical ventilation (MV). Interleukin (IL)-5 and CC chemokines have been directly implicated in the pathophysiology of allergic asthma. However, their involvement in SA had not been determined. The aim of this study was to evaluate the production of CC chemokines and of IL-5 in airways from ventilated patients with SA as compared with mild asthma (A), and to assess the role of these mediators in eosinophil recruitment. We measured levels of the chemokines monocyte chemotactic proteins (MCPs)-1 and -3; regulated on activation, normal T-cell expressed and secreted (RANTES); macrophage inflammatory peptide (MIP)-1 \u03b1; and eotaxin; and of the cytokine IL-5 in bronchial lavage fluid (BLF) from 10 SA patients, four patients without respiratory disease but undergoing ventilation (V) who were receiving MV, 11 patients with A, and eight healthy volunteers (C). We further evaluated in vitro eosinophil chemotactic activity of BLF from the various groups. Levels of MCP-1, MIP-1 \u03b1, RANTES, and IL-5 were significantly higher in the SA than in the V, A, and C groups. MCP-3 and eotaxin values were not significantly different in the SA and other groups; however, their levels, as well as those of MIP-1 \u03b1, RANTES, and IL-5 correlated with eosinophil influx. Eosinophil chemotactic activity in BLF was increased in asthmatic subjects (A and SA groups) as compared with the other groups, and in SA patients as compared with A patients. Addition of neutralizing anti\u2013IL-5, anti\u2013MCP-3, anti-eotaxin, and anti-RANTES antibodies significantly inhibited the eosinophil chemotactic activity as compared with that of native BLF. This study shows that the levels of various CC chemokines and IL-5 are increased in airways of SA patients, and are potentially involved in eosinophil recruitment.<\/jats:p>","DOI":"10.1164\/ajrccm.162.2.9907014","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:23:08Z","timestamp":1365085388000},"page":"586-592","source":"Crossref","is-referenced-by-count":59,"title":["CC Chemokines and Interleukin-5 in Bronchial Lavage Fluid from Patients with Status Asthmaticus"],"prefix":"10.1093","volume":"162","author":[{"given":"ISABELLE","family":"TILLIE-LEBLOND","sequence":"first","affiliation":[{"name":"Unit\u00e9 de la Institute National de la Sant\u00e9 et de Recherche Medicale U 416, Institut Pasteur de Lille and Clinique des Maladies Respiratoires, Centre Hopitalier de Recherche Universitaire, Lille, France; Division des Soins Intensifs de M\u00e9decine, University Hospital, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAMIDA","family":"HAMMAD","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de la Institute National de la Sant\u00e9 et de Recherche Medicale U 416, Institut Pasteur de Lille and Clinique des Maladies Respiratoires, Centre Hopitalier de Recherche Universitaire, Lille, France; Division des Soins Intensifs de M\u00e9decine, University Hospital, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SOPHIE","family":"DESURMONT","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de la Institute National de la Sant\u00e9 et de Recherche Medicale U 416, Institut Pasteur de Lille and Clinique des Maladies Respiratoires, Centre Hopitalier de Recherche Universitaire, Lille, France; Division des Soins Intensifs de M\u00e9decine, University Hospital, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00c9R\u00d4ME","family":"PUGIN","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de la Institute National de la Sant\u00e9 et de Recherche Medicale U 416, Institut Pasteur de Lille and Clinique des Maladies Respiratoires, Centre Hopitalier de Recherche Universitaire, Lille, France; Division des Soins Intensifs de M\u00e9decine, University Hospital, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BENO\u00ceT","family":"WALLAERT","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de la Institute National de la Sant\u00e9 et de Recherche Medicale U 416, Institut Pasteur de Lille and Clinique des Maladies Respiratoires, Centre Hopitalier de Recherche Universitaire, Lille, France; Division des Soins Intensifs de M\u00e9decine, University Hospital, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDR\u00c9-BERNARD","family":"TONNEL","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de la Institute National de la Sant\u00e9 et de Recherche Medicale U 416, Institut Pasteur de Lille and Clinique des Maladies Respiratoires, Centre Hopitalier de Recherche Universitaire, Lille, France; Division des Soins Intensifs de M\u00e9decine, University Hospital, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PHILIPPE","family":"GOSSET","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de la Institute National de la Sant\u00e9 et de Recherche Medicale U 416, Institut Pasteur de Lille and Clinique des Maladies Respiratoires, Centre Hopitalier de Recherche Universitaire, Lille, France; Division des Soins Intensifs de M\u00e9decine, University Hospital, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,8,1]]},"reference":[{"key":"2026032708241514500_B1","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1164\/ajrccm\/140.6.1745","article-title":"Bronchial biopsies in asthma.","volume":"140","author":"Jeffery","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708241514500_B2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1164\/arrd.1985.131.4.599","article-title":"Damage of the airway epithelium and bronchial reactivity in patients with asthma.","volume":"121","author":"Laitinen","year":"1985","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708241514500_B3","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1164\/ajrccm\/139.3.806","article-title":"Cellular events in the bronchi in mild asthma and after bronchial provocation.","volume":"139","author":"Beasley","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708241514500_B4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1378\/chest.38.6.616","article-title":"Causes of death and pathologic findings in 304 cases of bronchial asthma.","volume":"38","author":"Messer","year":"1960","journal-title":"Dis. Chest"},{"key":"2026032708241514500_B5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/thx.14.4.341","article-title":"Death in asthmatics.","volume":"14","author":"Cardell","year":"1959","journal-title":"Thorax"},{"key":"2026032708241514500_B6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/ajrccm\/147.2.405","article-title":"The structure of large and small airways in nonfatal and fatal asthma.","volume":"147","author":"Carroll","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708241514500_B7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/ajrccm\/148.3.713","article-title":"Sudden-onset fatal asthma: distinct entity with few neutrophils and relatively more neutrophils in the airway submucosa?","volume":"148","author":"Sur","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708241514500_B8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1164\/ajrccm.157.2.97-02099","article-title":"Bronchial neutrophilia in patients with noninfectious status asthmaticus.","volume":"157","author":"Lamblin","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708241514500_B9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1084\/jem.186.4.601","article-title":"Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo.","volume":"186","author":"Humbles","year":"1997","journal-title":"J. Exp. Med."},{"key":"2026032708241514500_B10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm0496-449","article-title":"Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia.","volume":"2","author":"Garcia-Zepeda","year":"1996","journal-title":"Nat. Med."},{"key":"2026032708241514500_B11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/all.1999.54.1.15","article-title":"Regulation and modulation of eosinophil effector functions.","volume":"54","author":"Elsner","year":"1999","journal-title":"Allergy"},{"key":"2026032708241514500_B12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2222.1999.00522.x","article-title":"Chemokines and IL-5: major players of eosinophil recruitment in asthma.","volume":"29","author":"Teran","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"2026032708241514500_B13","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.4049\/jimmunol.158.10.4953","article-title":"Monocyte chemotatic protein-3 (MCP-3)\/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3\/FIC antibody.","volume":"158","author":"Stafford","year":"1997","journal-title":"J. Immunol."},{"key":"2026032708241514500_B14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.179.2.751","article-title":"Monocyte chemotactic protein-3 is a most effective basophil- and eosinophil-activating chemokine.","volume":"179","author":"Dahinden","year":"1994","journal-title":"J. Exp. Med."},{"key":"2026032708241514500_B15"},{"key":"2026032708241514500_B16","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1084\/jem.176.6.1489","article-title":"RANTES and macrophage inflammatory protein-1\u03b1 induce the migration and activation of normal human eosinophil granulocytes.","volume":"176","author":"Rot","year":"1992","journal-title":"J. Exp. Med."},{"key":"2026032708241514500_B17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-2478(97)02709-0","article-title":"Monocyte chemotactic and activating factor\/monocyte chemoattractant protein in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis: relationship to lung function tests, bronchial hyper-responsiveness and cytology of bronchoalveolar lavage fluid.","volume":"58","author":"Rozyk","year":"1997","journal-title":"Immunol. Lett."},{"key":"2026032708241514500_B18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/eji.1830190420","article-title":"Recombinant human interleukin-5 is a selective eosinophil chemoattractant.","volume":"19","author":"Wang","year":"1989","journal-title":"Eur. J. Immunol."},{"key":"2026032708241514500_B19","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1182\/blood.V79.11.2952.bloodjournal79112952","article-title":"Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects.","volume":"79","author":"Sehmi","year":"1992","journal-title":"Blood"},{"key":"2026032708241514500_B20","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1084\/jem.167.5.1737","article-title":"Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor.","volume":"167","author":"Yamaguchi","year":"1988","journal-title":"J. Exp. Med."},{"key":"2026032708241514500_B21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/ajrccm.159.2.9805115","article-title":"Proinflammatory activity in bronchial lavage fluids of status asthmaticus patients.","volume":"150","author":"Tillie-Leblond","year":"1999","journal-title":"Am. Rev. Respir. Crit. Care Med."},{"key":"2026032708241514500_B22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1164\/ajrccm\/136.1.225","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma.","volume":"136","author":"American Thoracic Society","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026032708241514500_B23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1398-9995.1981.tb01818.x","article-title":"Heterogeneity of bronchial asthma: subpopulations or different stages of the disease.","volume":"36","author":"Aas","year":"1981","journal-title":"Allergy"},{"key":"2026032708241514500_B24","first-page":"324","article-title":"Biopsy and possible efficacy of fiberoptic bronchoscopy with lavage in the management of refractory asthma with mucous impaction.","volume":"67","author":"Lang","year":"1991","journal-title":"Ann. Allergy"},{"key":"2026032708241514500_B25","first-page":"654","article-title":"Presence of factors chemotactic for granulocytes in hypereo-sinophilic syndrome sera: relation with alterations in eosinophil migration.","volume":"65","author":"Gosset","year":"1986","journal-title":"Clin. Exp. Immunol."},{"key":"2026032708241514500_B26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.182.4.1169","article-title":"Cooperation between interleukin-5 and the chemokine, eotaxin, to induce eosinophil accumulation in vivo.","volume":"182","author":"Collins","year":"1995","journal-title":"J. Exp. Med."},{"key":"2026032708241514500_B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/ajrcmb.16.1.8998072","article-title":"Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony stimulating factor, and IL-3.","volume":"16","author":"Humbert","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2026032708241514500_B28","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.4049\/jimmunol.159.9.4593","article-title":"Increased expression of eotaxin in bronchioalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation.","volume":"159","author":"Lamkhioued","year":"1997","journal-title":"J. Immunol."},{"key":"2026032708241514500_B29","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1164\/ajrccm.153.4.8616572","article-title":"Increased MCP-1, RANTES, and MIP-1\u03b1 in bronchoalveolar lavage fluid of allergic asthmatic patients.","volume":"153","author":"Alam","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708241514500_B30","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/ajrccm.156.5.9610064","article-title":"Release of RANTES, MIP-1\u03b1, and MCP-1 into asthmatic airways following endobronchial allergen challenge.","volume":"156","author":"Holgate","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026032708241514500_B31","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.4049\/jimmunol.157.4.1806","article-title":"Eosinophil recruitment following endobronchial allergen challenge is associated with the release of RANTES into asthmatic airways.","volume":"157","author":"Teran","year":"1996","journal-title":"J. Immunol."},{"key":"2026032708241514500_B32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.188.1.157","article-title":"The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness.","volume":"188","author":"Gonzalo","year":"1998","journal-title":"J. Exp. Med."},{"key":"2026032708241514500_B33","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.4049\/jimmunol.156.11.4422","article-title":"Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes.","volume":"156","author":"Meagher","year":"1996","journal-title":"J. Immunol."},{"key":"2026032708241514500_B34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4049\/jimmunol.155.1.410","article-title":"Expression of the chemokine RANTES by a human bronchial epithelial cell line: modulation by cytokines and glucocorticoids.","volume":"155","author":"Stellato","year":"1995","journal-title":"J. Immunol."},{"key":"2026032708241514500_B35","doi-asserted-by":"crossref","first-page":"8069","DOI":"10.1073\/pnas.92.17.8069","article-title":"The cis-acting phorbol ester 12-O-tetradecanoylphorbol 13-acetate-responsive element is involved in shear stress-induced monocyte chemotactic protein-1 gene expression.","volume":"92","author":"Shyy","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"2026032708241514500_B36","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1165\/ajrcmb.10.2.8110469","article-title":"Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects.","volume":"10","author":"Sousa","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2026032708241514500_B37","first-page":"1861","article-title":"CC chemokines differentially alter interleukin-4 production from lymphocytes.","volume":"150","author":"Lukacs","year":"1997","journal-title":"Am. J. Pathol."},{"key":"2026032708241514500_B38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1165\/ajrcmb\/7.2.126","article-title":"Not another cytokine: MCP-1 and respiratory disease.","volume":"7","author":"Rollins","year":"1992","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/162\/2\/586\/67534496\/ajrccm_162_2_586.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/162\/2\/586\/67534496\/ajrccm_162_2_586.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:24:25Z","timestamp":1774614265000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/162\/2\/586\/8540818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,1]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2000,8,1]]},"published-print":{"date-parts":[[2000,8,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.162.2.9907014","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,8]]},"published":{"date-parts":[[2000,8,1]]}}}